Stevanato Group
NYSE:STVN Community- 1 Narratives written by author
- 0 Comments on narratives written by author
- 2 Fair Values set on narratives written by author
WA
Consensus Narrative from 10 Analysts
Shift To Ready-to-Use Systems Will Boost Future Productivity In Bio-Pharma
Key Takeaways Optimizing the Engineering segment and strategic shifts towards ready-to-use systems are expected to drive cost savings, improve margins, and boost productivity. Recovery in vial orders and capacity expansion projects aim to enhance revenue and profitability through increased high-value solution offerings.
View narrativeUS$26.41
FV
20.9% undervalued intrinsic discount9.32%
Revenue growth p.a.
1users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
23 days ago author updated this narrative